Real FX - Search Results

1

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtröder K, Jensen JB, Strandgaard T, Nordentoft I, Christensen E, Sokac M, Birkbak NJ, Maretty L, Hermann GG, Petersen AC, Weyerer V, Grimm MO, Horstmann M, Sjödahl G, Höglund M, Steiniche T, Mogensen K, de Reyniès A, Nawroth R, Jordan B, Lin X, Dragicevic D, Ward DG, Goel A, Hurst CD, Raman JD, Warrick JI, Segersten U, Sikic D, van Kessel KEM, Maurer T, Meeks JJ, DeGraff DJ, Bryan RT, Knowles MA, Simic T, Hartmann A, Zwarthoff EC, Malmström PU, Malats N, Real FX, Dyrskjøt L. Lindskrog SV, et al. Among authors: real fx. Nat Commun. 2021 Apr 16;12(1):2301. doi: 10.1038/s41467-021-22465-w. Nat Commun. 2021. PMID: 33863885 Free PMC article.

2

Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.

Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Malats N, et al. Among authors: real fx. J Clin Oncol. 1995 Jul;13(7):1679-86. doi: 10.1200/JCO.1995.13.7.1679. J Clin Oncol. 1995. PMID: 7602358

3

Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations.

Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. Porta M, et al. Among authors: real fx. J Clin Epidemiol. 1994 Sep;47(9):1069-79. doi: 10.1016/0895-4356(94)90123-6. J Clin Epidemiol. 1994. PMID: 7730910

4

Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings.

Porta M, Malats N, Corominas JM, Rifà J, Piñol JL, Real FX; Pankras I Project Investigators. Porta M, et al. Among authors: real fx. Ann Epidemiol. 2002 Jan;12(1):7-14. doi: 10.1016/s1047-2797(01)00267-8. Ann Epidemiol. 2002. PMID: 11750234

5

Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

Aguilar S, Corominas JM, Malats N, Pereira JA, Dufresne M, Real FX, Navarro P. Aguilar S, et al. Among authors: real fx. Am J Pathol. 2004 Oct;165(4):1129-39. doi: 10.1016/S0002-9440(10)63374-3. Am J Pathol. 2004. PMID: 15466380 Free PMC article.

6

FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.

Hernández S, López-Knowles E, Lloreta J, Kogevinas M, Jaramillo R, Amorós A, Tardón A, García-Closas R, Serra C, Carrato A, Malats N, Real FX. Hernández S, et al. Among authors: real fx. Clin Cancer Res. 2005 Aug 1;11(15):5444-50. doi: 10.1158/1078-0432.CCR-05-0122. Clin Cancer Res. 2005. PMID: 16061860

7

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

Malats N, Bustos A, Nascimento CM, Fernandez F, Rivas M, Puente D, Kogevinas M, Real FX. Malats N, et al. Among authors: real fx. Lancet Oncol. 2005 Sep;6(9):678-86. doi: 10.1016/S1470-2045(05)70315-6. Lancet Oncol. 2005. PMID: 16129368 Review.

8

Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas.

Hernández S, López-Knowles E, Lloreta J, Kogevinas M, Amorós A, Tardón A, Carrato A, Serra C, Malats N, Real FX. Hernández S, et al. Among authors: real fx. J Clin Oncol. 2006 Aug 1;24(22):3664-71. doi: 10.1200/JCO.2005.05.1771. J Clin Oncol. 2006. PMID: 16877735

9

PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.

López-Knowles E, Hernández S, Malats N, Kogevinas M, Lloreta J, Carrato A, Tardón A, Serra C, Real FX. López-Knowles E, et al. Among authors: real fx. Cancer Res. 2006 Aug 1;66(15):7401-4. doi: 10.1158/0008-5472.CAN-06-1182. Cancer Res. 2006. PMID: 16885334

10

The p53 pathway and outcome among patients with T1G3 bladder tumors.

López-Knowles E, Hernández S, Kogevinas M, Lloreta J, Amorós A, Tardón A, Carrato A, Kishore S, Serra C, Malats N, Real FX; EPICURO Study Investigators. López-Knowles E, et al. Among authors: real fx. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6029-36. doi: 10.1158/1078-0432.CCR-06-0206. Clin Cancer Res. 2006. PMID: 17062677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page